期刊文献+

风心病合并肺动脉高压体外循环后前列腺素E_1抵抗现象的研究 被引量:3

Resistance to prostaglandin E_1 in postoperative early stage of valvular replacement in rheumatic heart disease patients
下载PDF
导出
摘要 目的探讨风心病合并肺动脉高压患者在围术期治疗中前列腺素E1(PGE1)的作用规律,为临床提供理论依据。方法28例分为2组:实验组(A组)14例,于术中停体外循环(CPB)后开始应用PGE1,20ng.kg-1.min-1,之后每10分钟增加20ng.kg-1.min-1,直至100ng.kg-1.min-1维持10min,连续观察体肺循环压力变化,间隔10min测量心脏指数(CI)1次,共测量6次;其中7例(A1)术后24h重复上述操作1次,其余7例(A2)采用生理盐水作为对照;对照组(B组)14例,术中及手术当日均不使用前列腺素E1,其中7例(B1)术后24h按A组方法给药1次,其余7例(B2)采用生理盐水作为对照。术后24h实验组14例(C组=A1+B1),对照组14例(D组=A2+B2)。结果术中A组和B组平均肺动脉压(MPAP)下降比较相差不显著(P>0.05),心脏指数(CI)、体循环阻力(SVR)、肺循环阻力(PVR)、肺动脉楔压(PAWP)变化均无显著性差异(P>0.05);术后24hC、D组平均肺动脉压(MPAP)下降相差显著(P<0.05),两组心脏指数(CI)变化相差非常显著(P<0.01)。结论风心病合并肺动脉高压患者在瓣膜置换术后,麻醉状况下对前列腺素E1存在抵抗现象,而在清醒状况下前列腺素E1能扩张肺血管,降低肺动脉压,提高心脏指数,改善心功能。 Objective To study the rule of surgical treatment for rheumatic heart disease in the postoperative stage of valve replacement. Methods Twenty-eight cases, suffered from rheumatic heart disease, were randomly divided into two groups, group A and B. In group A, 14 cases were given 20 - 100 ng· kg^-1· min^-1 of prostaglandin E1 (PGE1) after the cardiopulmonary bypass (CPB) was stopped, and its velocity (dosage) was increased by 20 ng · kg^-1· min^-1 every 10 minutes. When up to 100 ng · kg^-1· min^-1, the velocity was held on for 10 minutes, then seized. PGE1 was swapped when it was used for 1 h. Twenty-four hours later, 7 cases of group A (A1) were given PGE1 once more as the same as the day before; the other 7 cases (A2) were given normal saline instead as for controls. In group B, no cases were given PGE1 during operation or on the day of operation. Twenty-four hours later, 7 cases (B1) were given PGE1 as that of A1, and the other 7 cases (B2) as that in group A2. In the hour of PGE1 injection, the blood pressure (SABP, DABP, MABP), pulmonary pressure (SPAP, DPAP, MPAP, PAWP), systemic vascular resistance (SVR), and pulmonary vascular resistance (PVR) were measured via Swan-Ganz catheter. Results There was not significant difference of parameters mentioned above between group A and group B. Twenty-four hours after operation, MPAP, PAWP and PVR in group C (A1 + B1 ) were much lower than those in group D ( A2 + B2). Conclusion The effect of PGE1 on pressure of pulmonary artery could not be seen when the patients were in anesthesia, so during mitral replacement operation it might be of some resistance.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第9期792-795,共4页 Journal of Third Military Medical University
关键词 风心病 肺动脉高压 前列腺素E2 rheumatic heart disease pulmonary hypertension PGE1
  • 相关文献

参考文献12

二级参考文献22

  • 1王福庄,丁爱石.海马培养细胞的缺氧损伤及降钙素基因相关肽的保护作用[J].中国应用生理学杂志,1994,10(4):317-321. 被引量:56
  • 2侯凡,李震一,孟素荣,李爱民,张晓燕,祝善俊.前列腺素E_1对风湿性二尖瓣病变合并肺动脉高压患者血液动力学的影响[J].中国循环杂志,1995,10(10):591-593. 被引量:13
  • 3苏应衡 郭兰敏.实用胸部外科学:第1版[M].山东:科学技术出版社,1996.996-998. 被引量:1
  • 4Toyo-oka T, Sugimoto T. Editorial comment : Endothelin: Key to coronary vasospasma? [letter; comment].Circulation, 1991,84(3) :1451 - 1452. 被引量:1
  • 5Bell D,McDermott B J. Calcitonin gene-related peptide stimulates a positive contractile response in rat ventricular cardiomyocytes [J]. J Cardiovasc Pharmacol, 1994.23(6):1011- 1021. 被引量:1
  • 6Franco-Cereceda A,Saria A, Lundberg J M, et al. Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain[J]. Acta Physiol Scand, 1989,135 (2) :173- 187. 被引量:1
  • 7Li Y J,Xiao Z S,Peng H W. Calcitonin gene-related peptide-induced preconditioning protects against ischemiareperfusion injury in isolated rat hearts [J]. Eur J Pharmacol, 1996,311 (2- 3) : 163- 167. 被引量:1
  • 8WAN S,YIM A. Cytokines in myocardial injury:impact on cardiac surgical approach [J].Eur J Cardiothorac Surg,1999,16(suppl,1):S107-S111. 被引量:1
  • 9ROMSON J L,HOOK B G,Kunkel S L,et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog [J].Circulation,1983,67:1016-1023. 被引量:1
  • 10YASUHIKO SUGAWARA,KEIICHI KUBOTA,TSUTOMU OGURA, et al. Protective of PGE1 against ischemia/reperfusion-induced liver injury;results of a prospective,randomized study in cirrhotic patients undergoing subsegmentectomy [J].Hepatology,1998,29:969-976. 被引量:1

共引文献20

同被引文献30

  • 1兰艳莉,毛君晓,李桂英.护理干预对前列腺素E_1治疗冠心病心绞痛副作用的影响[J].赣南医学院学报,2005,25(5):696-697. 被引量:1
  • 2马平霞,段美容,李玲.前列腺素E1治疗肺动脉高压时不良反应的观察及护理[J].中国误诊学杂志,2007,7(14):3313-3314. 被引量:6
  • 3黄霞丽,陈世厚,袁艳.外涂丁卡因预防静脉滴注前列腺素E_1不良反应效果观察[J].临床误诊误治,2007,20(5):89-90. 被引量:1
  • 4Heider P, Wildgruber M, Wolf O, et al. Improvement of microcireulation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1 [J]. Prostaglandins Other Lipid Mediat, 2009, 88(1-2): 23-30. 被引量:1
  • 5Wu CC, Wu CI, Wang WY, et al. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins[J].Planta Med, 2007, 73(5): 439-443. 被引量:1
  • 6Gensch C, Clever Y, Werner C, et al. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis[J]. J Mol Cell Cardiol, 2007, 42(3): 670-677. 被引量:1
  • 7Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostaglandin E 1-induced angiogenesis in the myocardium of patients with ischemic heart disease[J]. Cardiovasc Res, 2002, 56(2): 214-224. 被引量:1
  • 8Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical benefit of prostaglandin El-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium[J]. Biomed Pharmacother, 2003, 57(3-4): 173-178. 被引量:1
  • 9von Scheidt W, Costard-Jaeckle A, Stempfle M, et al. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study[J]. J Heart Lung Transplant, 2006, 25(9): 1070-1076. 被引量:1
  • 10Dresdale D T, Schultz M, Michtom R J. Primary pulmonary hypertension. I. Clinical and hemodynamic study [J]. Am J Med, 1951, 11 (6) : 686 -705. 被引量:1

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部